CRISPR&Cas遺伝子の世界市場2020-2027:製品・サービス別(ベクターベースCas、DNA-freeCas、細胞株エンジニアリング)、用途別、最終用途別

◆英語タイトル:CRISPR & Cas Genes Market Size, Share & Trends Analysis Report By Product & Service (Vector-basedCas, DNA-freeCas, Cell Line Engineering), By Application, By End Use, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20JN256
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年5月
◆ページ数:212
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:クローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、CRISPR&Cas遺伝子の世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、産業動向、競争状況、製品・サービス別(ベクターベースCas、DNA-freeCas、細胞株エンジニアリング)分析、用途別分析、最終用途別分析、地域別分析、企業情報など、今後の市場展望をまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場の要因・動向・範囲
・産業動向
・競争状況
・CRISPR&Cas遺伝子の世界市場規模:製品・サービス別(ベクターベースCas、DNA-freeCas、細胞株エンジニアリング)
・CRISPR&Cas遺伝子の世界市場規模:用途別
・CRISPR&Cas遺伝子の世界市場規模:最終用途別
・CRISPR&Cas遺伝子の世界市場規模:地域別
・企業情報
【レポートの概要】

CRISPR & Cas Genes Market Growth & Trends

The global clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes market size is expected to reach USD 4.88 billion by 2027, expanding at a CAGR of 16.6% from 2020 to 2027, according to a new report by Grand View Research, Inc. Rise in the adoption of CRISPR technology in epigenetics, therapeutics, human germline editing, plant genome editing, and other fields of biotechnology is expected to drive the market.

Presence of a large number of service providers that provide knockout, knock-in, gene repression, gene activation, and other cell line engineering services propel the growth of cell line engineering services. In biomedical applications, genome engineering held the largest revenue share in 2019. Adoption of gene editing techniques for human- and non-human-based genomic engineering is one of the key factors that drive the segment.

The molecular scissor can facilitate the detection of viruses, allowing the development of cost-effective, robust, and rapid point-of-care diagnostics. It allows the detection of viruses at a level of molecular concentration that researchers rarely assess. Sherlock Bioscience estimated that a CRISPR-powered diagnostic test would be available in the future at a reasonable price. In recent times, the most important innovation has been the development of a test for COVID-19.

In March 2020, Mesa Biotech announced FDA authorization for its Accula device, a hand-held COVID-19 diagnostic test. Similarly, in April 2020, CSIR lab announced the development of a paper-strip test for Covid-19 that uses CRISPR-Cas9 to target and identifies the genomic sequences of the virus. Unlike the PCR tests, this test is available at a very low price, USD 6.59 (INR 1 = USD 0.013). Therefore, such initiatives are expected to encourage other players to leverage this crisis and launch novel products.

CRISPR & Cas Genes Market Report Highlights

• The product segment is anticipated to dominate the market throughout the forecast period. This is attributed to the presence of enhanced individual products that can serve multiple purposes including genome engineering, specific genome cleavage using gRNAs, easy gene knockouts, along with reduced off-target cutting, and increased specificity

• Cell line engineering services accounted for the largest market share in 2019. The development of this technology has simplified the genome engineering process to a large extent

• In biomedical applications, genome engineering held the largest revenue share in 2019 as a result of an increase in the adoption of genome editing techniques for modifications in germline and therapeutics development

• Recent advancements in CRISPR/Cas genome editing allow targeted modification in crops, thereby promising crop improvement and revenue generation in the market

• A significant number of research studies carried out to develop disease-specific novel therapies and presence of a huge clinical pipeline that integrates the application of this gene-editing technology are expected to boost revenue generation for the biotechnology and pharmaceutical companies segment

• Asia Pacific is anticipated to witness the fastest growth over the forecast period. China holds a significant position in the CRISPR market and is increasingly exploring genome-editing for the development of medicines. The country has launched several CRISPER-based clinical trials, especially for cancer treatment.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Information Or Data Analysis
1.3 Market Model
1.3.1 Parent Market Study
1.3.2 Crispr And Cas Genes Market Study
1.3.2.1 Market Study, By Product & Service
1.3.2.2 Market Study, By Application
1.3.2.3 Market Study, By End – Use
1.3.2.4 Market Study, By Region
1.4 Objectives
1.4.1 Objective 1:
1.4.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Snapshot, 2019 (USD Million)
Chapter 3 Crispr And Cas Genes Market Variables, Trends & Scope
3.1 Market Trends & Outlook
3.2 Market Segmentation & Scope
3.3 Market Lineage Outlook
3.3.1 Parent Market Outlook
3.3.2 Related/Ancillary Market Outlook
3.4 Crispr And Cas Genes: Patent Landscape
3.4.1 By End – Use Settings
3.4.2 By Variants Of Crispr Enzymes
3.5 Penetration And Growth Prospect Mapping, By Biomedical Applications, 2019
3.6 Potential Threat Analysis To Crispr Technology
3.6.1 Variations In The Crispr System
3.7 Investors Perspective Analysis
3.8 User Perspective Analysis
3.9 Technology Mapping In Crispr Genome Editing Workflow
3.10 Developments And Innovations For Analysis Of Off – Target Effects
3.11 Crispr Technologies: Clinical Penetration
3.11.1 Human Therapeutics
3.11.2 Diagnostics
3.11.3 Microbiome Research And Drug Resistance
3.11.4 Animal Disease Models
Chapter 4 Industry Outlook
4.1 Market Dynamics
4.1.1 Market Driver Analysis
4.1.1.1 Rising Adoption In Diverse Fields Of Biotechnology
4.1.1.1.1 Epigenetics
4.1.1.1.2 Medicine
4.1.1.1.3 Human Germline Editing
4.1.1.1.4 Tool For Qualitative And Quantitative Plant Genome Editing
4.1.1.2 Technological Advancements In Crispr
4.1.1.3 Introduction Of Anti – Crispr Protein
4.1.1.4 Ongoing Competition For Crispr Commercialization
4.1.2 Market Restraint Analysis
4.1.2.1 Off – Target Effects Of Crispr Technology
4.1.2.2 Intellectual Property Disputes Pertaining To Cas
4.1.2.3 Ethical Concerns And Implications With Respect To Human Genome Editing
4.1.3 Market Opportunity Analysis
4.1.3.1 Expanding Gene & Cell Therapy Area
4.1.3.2 Government Fund In Genomic R&D
4.1.4 Market Challenge Analysis
4.1.4.1 Risks Pertaining To The Usage Of Genetically Modified Food
4.2 Policy Making & Regulation For Genetic Modification Using Crispr
4.3 Porter’s Five Forces Analysis
4.3.1 Threat Of New Entrants: Moderate
4.3.2 Competitive Rivalry: High
4.3.3 Threat Of Substitutes: Moderate
4.3.4 Bargaining Power Of Suppliers: Low
4.3.5 Bargaining Power Of Buyers: Moderate
4.4 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
4.4.1 Political & Legal
4.4.2 Economic
4.4.3 Technological
Chapter 5 Competitive Landscape
5.1 Companies (Diagnostic & Drug Developers) Leveraging Gene Editing Technologies
5.2 Major Deals & Strategic Alliances Analysis
5.3 Market Entry Strategies
5.3.1 Crispr Therapeutics: Business Translation
5.3.2 Crispr Gene Editing Companies’ Toolboxes
5.4 Crispr And Cas Genes Market: Pipeline Analysis
5.4.1 Editas Medicine
5.4.2 Intellia Therapeutics, Inc.
5.4.3 Crispr Therapeutics
5.4.4 Caribou Biosciences, Inc.
5.4.5 Egenesis
5.4.6 Beam Therapeutics
5.4.7 Ksq Therapeutics
5.4.8 Cibus
Chapter 6 Product & Service Business Analysis
6.1 Crispr And Cas Genes Market: Product & Service Movement Analysis
6.2 By Product
6.2.1 Global Crispr And Cas Genes Products Market, 2016 – 2027 (USD Million)
6.2.2 Kits & Enzymes
6.2.3 Global Crispr And Cas Genes Kits And Enzymes Market, 2016 – 2027 (USD Million)
6.2.3.1 Vector – Based Cas9
6.2.3.1.1 Global Vector – Based Cas9 Market, 2016 – 2027 (USD Million)
6.2.3.2 Dna – Free Cas9
6.2.3.2.1 Global Dna – Free Cas9 Market, 2016 – 2027 (USD Million)
6.2.4 Libraries
6.2.4.1 Global Crispr And Cas Genes Libraries Market, 2016 – 2027 (USD Million)
6.2.5 Design Tools
6.2.5.1 Global Crispr And Cas Genes Design Tool Market, 2016 – 2027 (USD Million)
6.2.6 Antibodies
6.2.6.1 Global Crispr And Cas Genes Antibodies Market, 2016 – 2027 (USD Million)
6.2.7 Others
6.2.7.1 Global Crispr And Cas Genes Market For Other Products, 2016 – 2027 (USD Million)
6.3 By Service
6.3.1 Global Crispr And Cas Genes Service Market, 2016 – 2027 (USD Million)
6.3.2 Cell Line Engineering
6.3.2.1 Global Cell Engineering Services Market, 2016 – 2027 (USD Million)
6.3.3 Grna Design
6.3.3.1 Global Grna Design Market, 2016 – 2027 (USD Million)
6.3.4 Microbial Gene Editing
6.3.4.1 Global Microbial Gene Editing Market, 2016 – 2027 (USD Million)
6.3.5 Dna Synthesis
6.3.5.1 Global Dna Synthesis Market, 2016 – 2027 (USD Million)
Chapter 7 Application Business Analysis
7.1 Crispr And Cas Genes Market: Application Movement Analysis
7.2 Biomedical
7.2.1 Global Crispr And Cas Genes Market For Biomedical, 2016 – 2027 (USD Million)
7.2.2 Genome Engineering
7.2.2.1 Global Crispr And Cas Genes Market For Genome Engineering, 2016 – 2027 (USD Million)
7.2.3 Disease Model Studies
7.2.3.1 Global Crispr And Cas Genes Market For Disease Model Studies, 2016 – 2027 (USD Million)
7.2.4 Functional Genomics
7.2.4.1 Global Crispr And Cas Genes Market For Functional Genomics, 2016 – 2027 (USD Million)
7.2.5 Epigenetics
7.2.5.1 Global Crispr And Cas Genes Market For Epigenetics, 2016 – 2027 (USD Million)
7.2.6 Others
7.2.6.1 Global Crispr And Cas Genes Market For Other Biomedical Applications, 2016 – 2027 (USD Million)
7.3 Agriculture
7.3.1 Global Crispr And Cas Genes Market For Agriculture, 2016 – 2027 (USD Million)
Chapter 8 End – Use Business Analysis
8.1 Crispr And Cas Genes Market: End – Use Movement Analysis
8.1.1 Biotechnology & Pharmaceutical Companies
8.1.1.1 Global Crispr And Cas Genes Market For Biotechnology & Pharmaceutical Companies, 2016 – 2027 (USD Million)
8.1.2 Academics & Government Research Institutes
8.1.2.1 Global Crispr And Cas Genes Market For Academics & Government Research Institutes, 2016 – 2027 (USD Million)
8.1.3 Contract Research Organizations (Cros)
8.1.3.1 Global Crispr And Cas Genes Market For Cros, 2016 – 2027 (USD Million)
Chapter 9 Regional Business Analysis
9.1 Crispr And Cas Genes Market: Regional Movement Analysis, 2019 And 2027
9.2 North America
9.2.1 North America Crispr And Cas Genes Market Estimates And Forecast, 2016 – 2027 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.2.2.2 U.S. Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.2.2.3 U.S. Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.2.3 Canada
9.2.3.1 Canada Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.2.3.2 Canada Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.2.3.3 Canada Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.3 Europe
9.3.1 Europe Crispr And Cas Genes Market Estimates And Forecast, 2016 – 2027 (USD Million)
9.3.2 Germany
9.3.2.1 Germany Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.3.2.2 Germany Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.3.2.3 Germany Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.3.3.2 U.K. Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.3.3.3 U.K. Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.3.4 France
9.3.4.1 France Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.3.4.2 France Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.3.4.3 France Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.3.5 Itlay
9.3.5.1 Italy Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.3.5.2 Italy Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.3.5.3 Italy Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.3.6 Spain
9.3.6.1 Spain Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.3.6.2 Spain Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.3.6.3 Spain Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Crispr And Cas Genes Market Estimates And Forecast, 2016 – 2027 (USD Million)
9.4.2 Japan
9.4.2.1 Japan Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.4.2.2 Japan Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.4.2.3 Japan Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.4.3 China
9.4.3.1 China Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.4.3.2 China Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.4.3.3 China Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.4.4 South Korea
9.4.4.1 South Korea Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.4.4.2 South Korea Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.4.4.3 South Korea Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.5 Latin America
9.5.1 Latin America Crispr And Cas Genes Market Estimates And Forecast, 2016 – 2027 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.5.2.2 Brazil Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.5.2.3 Brazil Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.5.3.2 Mexico Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.5.3.3 Mexico Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.6 Middle East & Africa (Mea)
9.6.1 Mea Crispr And Cas Genes Market Estimates And Forecast, 2016 – 2027 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.6.2.2 South Africa Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.6.2.3 South Africa Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia Crispr And Cas Genes Market Estimates And Forecast, By Product & Service, 2016 – 2027 (USD Million)
9.6.3.2 Saudi Arabia Crispr And Cas Genes Market Estimates And Forecast, By Application, 2016 – 2027 (USD Million)
9.6.3.3 Saudi Arabia Crispr And Cas Genes Market Estimates And Forecast, By End – Use, 2016 – 2027 (USD Million)
Chapter 10 Company Profiles
10.1 Top Crispr Innovators And Their Research Focus
10.2 Strategy Framework
10.3 Market Participant Categorization
10.4 Company Profiles
10.4.1 Astrazeneca
10.4.1.1 Company Overview
10.4.1.2 Financial Performance
10.4.1.3 Product Benchmarking
10.4.1.4 Strategic Initiatives
10.4.2 Addgene
10.4.2.1 Company Overview
10.4.2.2 Financial Performance
10.4.2.3 Product Benchmarking
10.4.3 Caribou Biosciences, Inc.
10.4.3.1 Company Overview
10.4.3.2 Financial Performance
10.4.3.3 Product Benchmarking
10.4.3.4 Strategic Initiatives
10.4.4 Cellectis
10.4.4.1 Company Overview
10.4.4.2 Calyxt, Inc.
10.4.4.2.1 Company Overview
10.4.4.3 Financial Performance
10.4.4.3.1 Financial Performance (Calyxt, Inc.)
10.4.4.4 Product Benchmarking
10.4.4.5 Strategic Initiatives
10.4.5 Crispr Therapeutics
10.4.5.1 Company Overview
10.4.5.2 Financial Performance
10.4.5.3 Product Benchmarking
10.4.5.4 Strategic Initiatives
10.4.6 Editas Medicine, Inc.
10.4.6.1 Company Overview
10.4.6.2 Financial Performance
10.4.6.3 Product Benchmarking
10.4.6.4 Strategic Initiatives
10.4.7 Egenesis
10.4.7.1 Company Overview
10.4.7.2 Financial Performance
10.4.7.3 Product Benchmarking
10.4.7.4 Strategic Initiatives
10.4.8 F. Hoffmann – La Roche Ltd.
10.4.8.1 Company Overview
10.4.8.2 Mirus Bio Llc
10.4.8.2.1 Company Overview
10.4.8.3 Financial Performance
10.4.8.3.1 Financial Performance (Mirus Bio Llc)
10.4.8.4 Product Benchmarking
10.4.9 Horizon Discovery Group Plc
10.4.9.1 Company Overview
10.4.9.2 Dharmacon, Inc.
10.4.9.2.1 Company Overview
10.4.9.3 Financial Performance
10.4.9.4 Product Benchmarking
10.4.9.5 Strategic Initiatives
10.4.10 Genscript
10.4.10.1 Company Overview
10.4.10.2 Financial Performance
10.4.10.3 Product Benchmarking
10.4.10.4 Strategic Initiatives
10.4.11 Danaher Corporation
10.4.11.1 Company Overview
10.4.11.2 Integrated Dna Technologies, Inc.
10.4.11.2.1 Company Overview
10.4.11.3 Financial Performance
10.4.11.3.1 Financial Performance (Integrated Dna Technologies, Inc.)
10.4.11.4 Product Benchmarking
10.4.11.5 Strategic Initiatives
10.4.12 Intellia Therapeutics, Inc.
10.4.12.1 Company Overview
10.4.12.2 Financial Performance
10.4.12.3 Product Benchmarking
10.4.12.4 Strategic Initiatives
10.4.13 Lonza
10.4.13.1 Company Overview
10.4.13.2 Financial Performance
10.4.13.3 Product Benchmarking
10.4.13.4 Strategic Initiatives
10.4.14 Merck Kgaa
10.4.14.1 Company Overview
10.4.14.2 Sigma – Aldrich Co. Llc
10.4.14.2.1 Company Overview
10.4.14.3 Financial Performance
10.4.14.4 Product Benchmarking
10.4.14.5 Strategic Initiatives
10.4.15 New England Biolabs
10.4.15.1 Company Overview
10.4.15.2 Financial Performance
10.4.15.3 Product Benchmarking
10.4.15.4 Strategic Initiatives
10.4.16 Takara Bio, Inc.
10.4.16.1 Company Overview
10.4.16.2 Financial Performance
10.4.16.3 Product Benchmarking
10.4.16.4 Strategic Initiatives
10.4.17 Thermo Fisher Scientific, Inc.
10.4.17.1 Company Overview
10.4.17.2 Financial Performance
10.4.17.3 Product Benchmarking
10.4.17.4 Strategic Initiatives
10.4.18 Synthego
10.4.18.1 Company Overview
10.4.18.2 Financial Performance
10.4.18.3 Product Benchmarking
10.4.18.4 Strategic Initiatives
10.4.19 Mammoth Biosciences
10.4.19.1 Company Overview
10.4.19.2 Financial Performance
10.4.19.3 Product Benchmarking
10.4.19.4 Strategic Initiatives
10.4.20 Inscripta, Inc.
10.4.20.1 Company Overview
10.4.20.2 Financial Performance
10.4.20.3 Product Benchmarking
10.4.20.4 Strategic Initiatives
10.4.21 Cibus
10.4.21.1 Company Overview
10.4.21.2 Financial Performance
10.4.21.3 Product Benchmarking
10.4.21.4 Strategic Initiatives
10.4.22 Beam Therapeutics
10.4.22.1 Company Overview
10.4.22.2 Financial Performance
10.4.22.3 Product Benchmarking
10.4.22.4 Strategic Initiatives
10.4.23 Plantedit
10.4.23.1 Company Overview
10.4.23.2 Product Benchmarking
10.4.23.3 Strategic Initiatives
10.4.24 Vertex Pharmaceuticals Incorporated
10.4.24.1 Company Overview
10.4.24.2 Financial Performance
10.4.24.3 Product Benchmarking
10.4.24.4 Strategic Initiatives
10.4.25 Hera Biolabs
10.4.25.1 Company Overview
10.4.25.2 Product Benchmarking
10.4.25.3 Strategic Initiatives
10.4.26 Origene Technologies, Inc.
10.4.26.1 Company Overview
10.4.26.2 Financial Performance
10.4.26.3 Product Benchmarking
10.4.26.4 Strategic Initiatives
10.4.27 Recombinetics, Inc.
10.4.27.1 Company Overview
10.4.27.2 Financial Performance
10.4.27.3 Product Benchmarking
10.4.27.4 Strategic Initiatives

List of Tables

TABLE 1 CRISPR - modified crops expected to be launched in the future
TABLE 2 Key collaborations between pharmaceutical and gene editing companies
TABLE 3 Key partnerships between pharmaceutical and gene editing companies
TABLE 4 Variations in the CRISPR system
TABLE 5 Methods to check genome editing on - target efficiency
TABLE 6 Unbiased methods to analyze off - target effects
TABLE 7 Collaboration between CAR - T companies & gene editing companies
TABLE 8 Comparison of natural Cas9 and Cas - like variants
TABLE 9 Pipeline analysis for Editas Medicine
TABLE 10 Pipeline analysis for Intellia Therapeutics, Inc.
TABLE 11 Pipeline analysis for CRISPR Therapeutics
TABLE 12 Pipeline analysis for Caribou Biosciences, Inc.
TABLE 13 Pipeline analysis for eGenesis
TABLE 14 Pipeline analysis for Beam Therapeutics
TABLE 15 Pipeline analysis for KSQ Therapeutics
TABLE 16 Pipeline analysis for Cibus
TABLE 17 Types of CRISPR screening libraries
TABLE 18 Types of CRISPR controls
TABLE 19 Types of cell engineering services
TABLE 20 North America CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 21 North America CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 22 North America CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 23 North America CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 24 North America CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 25 North America CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 26 North America CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 27 U.S. CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 28 U.S. CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 29 U.S. CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 30 U.S. CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 31 U.S. CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 32 U.S. CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 33 U.S. CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 34 Canada CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 35 Canada CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 36 Canada CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 37 Canada CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 38 Canada CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 39 Canada CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 40 Canada CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 41 Europe CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 42 Europe CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 43 Europe CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 44 Europe CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 45 Europe CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 46 Europe CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 47 Europe CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 48 Germany CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 49 Germany CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 50 Germany CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 51 Germany CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 52 Germany CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 53 Germany CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 54 Germany CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 55 U.K. CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 56 U.K. CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 57 U.K. CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 58 U.K. CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 59 U.K. CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 60 U.K. CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 61 U.K. CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 62 France CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 63 France CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 64 France CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 65 France CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 66 France CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 67 France CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 68 France CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 69 Italy CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 70 Italy CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 71 Italy CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 72 Italy CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 73 Italy CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 74 Italy CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 75 Italy CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 76 Spain CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 77 Spain CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 78 Spain CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 79 Spain CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 80 Spain CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 81 Spain CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 82 Spain CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 83 Asia Pacific CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 84 Asia Pacific CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 85 Asia Pacific CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 86 Asia Pacific CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 87 Asia Pacific CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 88 Asia Pacific CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 89 Asia Pacific CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 90 Japan CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 91 Japan CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 92 Japan CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 93 Japan CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 94 Japan CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 95 Japan CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 96 Japan CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 97 China CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 98 China CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 99 China CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 100 China CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 101 China CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 102 China CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 103 China CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 104 South Korea CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 105 South Korea CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 106 South Korea CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 107 South Korea CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 108 South Korea CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 109 South Korea CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 110 South Korea CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 111 Latin America CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 112 Latin America CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 113 Latin America CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 114 Latin America CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 115 Latin America CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 116 Latin America CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 117 Latin America CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 118 Brazil CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 119 Brazil CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 120 Brazil CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 121 Brazil CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 122 Brazil CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 123 Brazil CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 124 Brazil CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 125 Mexico CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 126 Mexico CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 127 Mexico CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 128 Mexico CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 129 Mexico CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 130 Mexico CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 131 Mexico CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 132 MEA CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 133 MEA CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 134 MEA CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 135 MEA CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 136 MEA CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 137 MEA CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 138 MEA CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 139 South Africa CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 140 South Africa CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 141 South Africa CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 142 South Africa CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 143 South Africa CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 144 South Africa CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 145 South Africa CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)
TABLE 146 Saudi Arabia CRISPR and Cas genes market, by product & service, 2016 - 2027 (USD Million)
TABLE 147 Saudi Arabia CRISPR and Cas genes products market, by type, 2016 - 2027 (USD Million)
TABLE 148 Saudi Arabia CRISPR and Cas genes kits & enzymes market, by type, 2016 - 2027 (USD Million)
TABLE 149 Saudi Arabia CRISPR and Cas genes service market, by type, 2016 - 2027 (USD Million)
TABLE 150 Saudi Arabia CRISPR and Cas genes market, by application, 2016 - 2027 (USD Million)
TABLE 151 Saudi Arabia CRISPR and Cas genes biomedical applications market, by type, 2016 - 2027 (USD Million)
TABLE 152 Saudi Arabia CRISPR and Cas genes market, by end - use, 2016 - 2027 (USD Million)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[CRISPR&Cas遺伝子の世界市場2020-2027:製品・サービス別(ベクターベースCas、DNA-freeCas、細胞株エンジニアリング)、用途別、最終用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆